| Predicate |
Object |
| contentType |
Journal Article |
| endingPage |
11 |
| issn |
2090-2654
2090-2662 |
| pageRange |
724871-11 |
| publicationName |
Multiple Sclerosis International |
| startingPage |
724871 |
| bibliographicCitation |
Alkhawajah M, Oger J. When to Initiate Disease-Modifying Drugs for Relapsing Remitting Multiple Sclerosis in Adults? Multiple Sclerosis International. 2011;2011():1–11. doi: 10.1155/2011/724871. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b5e83a19858d63f3d462d64429eae1e6
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dfbf52c105df78bb5acb1c56282b7963 |
| date |
2011 |
| identifier |
https://pubmed.ncbi.nlm.nih.gov/PMC3195775
https://doi.org/10.1155/2011/724871
https://pubmed.ncbi.nlm.nih.gov/22096641 |
| isPartOf |
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/39553
https://portal.issn.org/resource/ISSN/2090-2662
https://portal.issn.org/resource/ISSN/2090-2654 |
| language |
English |
| source |
https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/ |
| title |
When to Initiate Disease-Modifying Drugs for Relapsing Remitting Multiple Sclerosis in Adults? |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3081884
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8532
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10606 |